GlassScriptPhysician profile
James S Gebhard
NPI 1811989114
$715.71
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.14 · 2021: $651.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nexus Spine, LLC | $580.17 | 2021 | |
| Bioventus LLC | $78.51 | 2019-2021 | |
| Cerapedics INC. | $45.53 | 2021 | |
| Misonix INC | $11.50 | 2019 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$1,431,374.81 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Gebhard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.